img

Global Nootropics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nootropics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Nootropics are medicines and natural derivatives that enhance cognitive functions including memory, motivation, and creativity in healthy persons. Nootropics have been accessible across the globe for many years and were constituted of ingredients such as multivitamins and caffeine – the products approved by the FDA as dietary supplements and termed as GRAS (generally regarded as safe).
The global Nootropics market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Nootropics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Nootropics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Nootropics is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Nootropics include Nootrobox, Cephalon, Purelife Bioscience, Peak Nootropics, Nootrico, SupNootropic Biological Technology, AlternaScript, Accelerated Intelligence and Onnit Labs, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Nootropics, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Nootropics by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Nootropics market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Nootropics market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Nootrobox
Cephalon
Purelife Bioscience
Peak Nootropics
Nootrico
SupNootropic Biological Technology
AlternaScript
Accelerated Intelligence
Onnit Labs
Powder City
Ceretropic
Nootropic Source
Clarity Nootropics
By Type
Attention and Focus
Memory Enhancement
Mood and Depression
Sleep and Anxiety
Others
By Application
Adult
Kid
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Nootropics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Nootropics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nootropics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Nootropics Definition
1.2 Market by Type
1.2.1 Global Nootropics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Attention and Focus
1.2.3 Memory Enhancement
1.2.4 Mood and Depression
1.2.5 Sleep and Anxiety
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Nootropics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Adult
1.3.3 Kid
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Nootropics Sales
2.1 Global Nootropics Revenue Estimates and Forecasts 2018-2034
2.2 Global Nootropics Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Nootropics Revenue by Region
2.3.1 Global Nootropics Revenue by Region (2018-2024)
2.3.2 Global Nootropics Revenue by Region (2024-2034)
2.4 Global Nootropics Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Nootropics Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Nootropics Sales Quantity by Region
2.6.1 Global Nootropics Sales Quantity by Region (2018-2024)
2.6.2 Global Nootropics Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Nootropics Sales Quantity by Manufacturers
3.1.1 Global Nootropics Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Nootropics Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Nootropics Sales in 2022
3.2 Global Nootropics Revenue by Manufacturers
3.2.1 Global Nootropics Revenue by Manufacturers (2018-2024)
3.2.2 Global Nootropics Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Nootropics Revenue in 2022
3.3 Global Nootropics Sales Price by Manufacturers
3.4 Global Key Players of Nootropics, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Nootropics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Nootropics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Nootropics, Product Offered and Application
3.8 Global Key Manufacturers of Nootropics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Nootropics Sales Quantity by Type
4.1.1 Global Nootropics Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Nootropics Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Nootropics Sales Quantity Market Share by Type (2018-2034)
4.2 Global Nootropics Revenue by Type
4.2.1 Global Nootropics Historical Revenue by Type (2018-2024)
4.2.2 Global Nootropics Forecasted Revenue by Type (2024-2034)
4.2.3 Global Nootropics Revenue Market Share by Type (2018-2034)
4.3 Global Nootropics Price by Type
4.3.1 Global Nootropics Price by Type (2018-2024)
4.3.2 Global Nootropics Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Nootropics Sales Quantity by Application
5.1.1 Global Nootropics Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Nootropics Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Nootropics Sales Quantity Market Share by Application (2018-2034)
5.2 Global Nootropics Revenue by Application
5.2.1 Global Nootropics Historical Revenue by Application (2018-2024)
5.2.2 Global Nootropics Forecasted Revenue by Application (2024-2034)
5.2.3 Global Nootropics Revenue Market Share by Application (2018-2034)
5.3 Global Nootropics Price by Application
5.3.1 Global Nootropics Price by Application (2018-2024)
5.3.2 Global Nootropics Price Forecast by Application (2024-2034)
6 North America
6.1 North America Nootropics Sales by Company
6.1.1 North America Nootropics Revenue by Company (2018-2024)
6.1.2 North America Nootropics Sales Quantity by Company (2018-2024)
6.2 North America Nootropics Market Size by Type
6.2.1 North America Nootropics Sales Quantity by Type (2018-2034)
6.2.2 North America Nootropics Revenue by Type (2018-2034)
6.3 North America Nootropics Market Size by Application
6.3.1 North America Nootropics Sales Quantity by Application (2018-2034)
6.3.2 North America Nootropics Revenue by Application (2018-2034)
6.4 North America Nootropics Market Size by Country
6.4.1 North America Nootropics Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Nootropics Revenue by Country (2018-2034)
6.4.3 North America Nootropics Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nootropics Sales by Company
7.1.1 Europe Nootropics Sales Quantity by Company (2018-2024)
7.1.2 Europe Nootropics Revenue by Company (2018-2024)
7.2 Europe Nootropics Market Size by Type
7.2.1 Europe Nootropics Sales Quantity by Type (2018-2034)
7.2.2 Europe Nootropics Revenue by Type (2018-2034)
7.3 Europe Nootropics Market Size by Application
7.3.1 Europe Nootropics Sales Quantity by Application (2018-2034)
7.3.2 Europe Nootropics Revenue by Application (2018-2034)
7.4 Europe Nootropics Market Size by Country
7.4.1 Europe Nootropics Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Nootropics Revenue by Country (2018-2034)
7.4.3 Europe Nootropics Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Nootropics Sales by Company
8.1.1 China Nootropics Sales Quantity by Company (2018-2024)
8.1.2 China Nootropics Revenue by Company (2018-2024)
8.2 China Nootropics Market Size by Type
8.2.1 China Nootropics Sales Quantity by Type (2018-2034)
8.2.2 China Nootropics Revenue by Type (2018-2034)
8.3 China Nootropics Market Size by Application
8.3.1 China Nootropics Sales Quantity by Application (2018-2034)
8.3.2 China Nootropics Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Nootropics Sales by Company
9.1.1 APAC Nootropics Sales Quantity by Company (2018-2024)
9.1.2 APAC Nootropics Revenue by Company (2018-2024)
9.2 APAC Nootropics Market Size by Type
9.2.1 APAC Nootropics Sales Quantity by Type (2018-2034)
9.2.2 APAC Nootropics Revenue by Type (2018-2034)
9.3 APAC Nootropics Market Size by Application
9.3.1 APAC Nootropics Sales Quantity by Application (2018-2034)
9.3.2 APAC Nootropics Revenue by Application (2018-2034)
9.4 APAC Nootropics Market Size by Region
9.4.1 APAC Nootropics Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Nootropics Revenue by Region (2018-2034)
9.4.3 APAC Nootropics Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Nootropics Sales by Company
10.1.1 Middle East, Africa and Latin America Nootropics Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Nootropics Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Nootropics Market Size by Type
10.2.1 Middle East, Africa and Latin America Nootropics Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Nootropics Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Nootropics Market Size by Application
10.3.1 Middle East, Africa and Latin America Nootropics Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Nootropics Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Nootropics Market Size by Country
10.4.1 Middle East, Africa and Latin America Nootropics Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Nootropics Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Nootropics Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Nootrobox
11.1.1 Nootrobox Company Information
11.1.2 Nootrobox Overview
11.1.3 Nootrobox Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Nootrobox Nootropics Products and Services
11.1.5 Nootrobox Nootropics SWOT Analysis
11.1.6 Nootrobox Recent Developments
11.2 Cephalon
11.2.1 Cephalon Company Information
11.2.2 Cephalon Overview
11.2.3 Cephalon Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Cephalon Nootropics Products and Services
11.2.5 Cephalon Nootropics SWOT Analysis
11.2.6 Cephalon Recent Developments
11.3 Purelife Bioscience
11.3.1 Purelife Bioscience Company Information
11.3.2 Purelife Bioscience Overview
11.3.3 Purelife Bioscience Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Purelife Bioscience Nootropics Products and Services
11.3.5 Purelife Bioscience Nootropics SWOT Analysis
11.3.6 Purelife Bioscience Recent Developments
11.4 Peak Nootropics
11.4.1 Peak Nootropics Company Information
11.4.2 Peak Nootropics Overview
11.4.3 Peak Nootropics Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Peak Nootropics Nootropics Products and Services
11.4.5 Peak Nootropics Nootropics SWOT Analysis
11.4.6 Peak Nootropics Recent Developments
11.5 Nootrico
11.5.1 Nootrico Company Information
11.5.2 Nootrico Overview
11.5.3 Nootrico Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Nootrico Nootropics Products and Services
11.5.5 Nootrico Nootropics SWOT Analysis
11.5.6 Nootrico Recent Developments
11.6 SupNootropic Biological Technology
11.6.1 SupNootropic Biological Technology Company Information
11.6.2 SupNootropic Biological Technology Overview
11.6.3 SupNootropic Biological Technology Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 SupNootropic Biological Technology Nootropics Products and Services
11.6.5 SupNootropic Biological Technology Nootropics SWOT Analysis
11.6.6 SupNootropic Biological Technology Recent Developments
11.7 AlternaScript
11.7.1 AlternaScript Company Information
11.7.2 AlternaScript Overview
11.7.3 AlternaScript Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 AlternaScript Nootropics Products and Services
11.7.5 AlternaScript Nootropics SWOT Analysis
11.7.6 AlternaScript Recent Developments
11.8 Accelerated Intelligence
11.8.1 Accelerated Intelligence Company Information
11.8.2 Accelerated Intelligence Overview
11.8.3 Accelerated Intelligence Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Accelerated Intelligence Nootropics Products and Services
11.8.5 Accelerated Intelligence Nootropics SWOT Analysis
11.8.6 Accelerated Intelligence Recent Developments
11.9 Onnit Labs
11.9.1 Onnit Labs Company Information
11.9.2 Onnit Labs Overview
11.9.3 Onnit Labs Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Onnit Labs Nootropics Products and Services
11.9.5 Onnit Labs Nootropics SWOT Analysis
11.9.6 Onnit Labs Recent Developments
11.10 Powder City
11.10.1 Powder City Company Information
11.10.2 Powder City Overview
11.10.3 Powder City Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Powder City Nootropics Products and Services
11.10.5 Powder City Nootropics SWOT Analysis
11.10.6 Powder City Recent Developments
11.11 Ceretropic
11.11.1 Ceretropic Company Information
11.11.2 Ceretropic Overview
11.11.3 Ceretropic Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Ceretropic Nootropics Products and Services
11.11.5 Ceretropic Recent Developments
11.12 Nootropic Source
11.12.1 Nootropic Source Company Information
11.12.2 Nootropic Source Overview
11.12.3 Nootropic Source Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Nootropic Source Nootropics Products and Services
11.12.5 Nootropic Source Recent Developments
11.13 Clarity Nootropics
11.13.1 Clarity Nootropics Company Information
11.13.2 Clarity Nootropics Overview
11.13.3 Clarity Nootropics Nootropics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Clarity Nootropics Nootropics Products and Services
11.13.5 Clarity Nootropics Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Nootropics Value Chain Analysis
12.2 Nootropics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nootropics Production Mode & Process
12.4 Nootropics Sales and Marketing
12.4.1 Nootropics Sales Channels
12.4.2 Nootropics Distributors
12.5 Nootropics Customers
13 Market Dynamics
13.1 Nootropics Industry Trends
13.2 Nootropics Market Drivers
13.3 Nootropics Market Challenges
13.4 Nootropics Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Nootropics Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Attention and Focus
Table 3. Major Manufacturers of Memory Enhancement
Table 4. Major Manufacturers of Mood and Depression
Table 5. Major Manufacturers of Sleep and Anxiety
Table 6. Major Manufacturers of Others
Table 7. Global Nootropics Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Nootropics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Nootropics Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Nootropics Revenue Market Share by Region (2018-2024)
Table 11. Global Nootropics Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Nootropics Revenue Market Share by Region (2024-2034)
Table 13. Global Nootropics Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Tablets)
Table 14. Global Nootropics Sales by Region (2018-2024) & (K Tablets)
Table 15. Global Nootropics Sales Market Share by Region (2018-2024)
Table 16. Global Nootropics Sales by Region (2024-2034) & (K Tablets)
Table 17. Global Nootropics Sales Market Share by Region (2024-2034)
Table 18. Global Nootropics Sales Quantity by Manufacturers (2018-2024) & (K Tablets)
Table 19. Global Nootropics Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Nootropics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Nootropics Revenue Share by Manufacturers (2018-2024)
Table 22. Global Nootropics Price by Manufacturers 2018-2024 (USD/Tablet)
Table 23. Global Key Players of Nootropics, Industry Ranking, 2021 VS 2022
Table 24. Global Nootropics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Nootropics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nootropics as of 2022)
Table 26. Global Key Manufacturers of Nootropics, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Nootropics, Product Offered and Application
Table 28. Global Key Manufacturers of Nootropics, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Nootropics Sales Quantity by Type (2018-2024) & (K Tablets)
Table 31. Global Nootropics Sales Quantity by Type (2024-2034) & (K Tablets)
Table 32. Global Nootropics Sales Quantity Share by Type (2018-2024)
Table 33. Global Nootropics Sales Quantity Share by Type (2024-2034)
Table 34. Global Nootropics Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Nootropics Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Nootropics Revenue Share by Type (2018-2024)
Table 37. Global Nootropics Revenue Share by Type (2024-2034)
Table 38. Nootropics Price by Type (2018-2024) & (USD/Tablet)
Table 39. Global Nootropics Price Forecast by Type (2024-2034) & (USD/Tablet)
Table 40. Global Nootropics Sales Quantity by Application (2018-2024) & (K Tablets)
Table 41. Global Nootropics Sales Quantity by Application (2024-2034) & (K Tablets)
Table 42. Global Nootropics Sales Quantity Share by Application (2018-2024)
Table 43. Global Nootropics Sales Quantity Share by Application (2024-2034)
Table 44. Global Nootropics Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Nootropics Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Nootropics Revenue Share by Application (2018-2024)
Table 47. Global Nootropics Revenue Share by Application (2024-2034)
Table 48. Nootropics Price by Application (2018-2024) & (USD/Tablet)
Table 49. Global Nootropics Price Forecast by Application (2024-2034) & (USD/Tablet)
Table 50. North America Nootropics Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Nootropics Sales Quantity by Company (2018-2024) & (K Tablets)
Table 52. North America Nootropics Sales Quantity by Type (2018-2024) & (K Tablets)
Table 53. North America Nootropics Sales Quantity by Type (2024-2034) & (K Tablets)
Table 54. North America Nootropics Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Nootropics Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Nootropics Sales Quantity by Application (2018-2024) & (K Tablets)
Table 57. North America Nootropics Sales Quantity by Application (2024-2034) & (K Tablets)
Table 58. North America Nootropics Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Nootropics Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Nootropics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Nootropics Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Nootropics Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Nootropics Sales Quantity by Country (2018-2024) & (K Tablets)
Table 64. North America Nootropics Sales Quantity by Country (2024-2034) & (K Tablets)
Table 65. Europe Nootropics Sales Quantity by Company (2018-2024) & (K Tablets)
Table 66. Europe Nootropics Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Nootropics Sales Quantity by Type (2018-2024) & (K Tablets)
Table 68. Europe Nootropics Sales Quantity by Type (2024-2034) & (K Tablets)
Table 69. Europe Nootropics Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Nootropics Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Nootropics Sales Quantity by Application (2018-2024) & (K Tablets)
Table 72. Europe Nootropics Sales Quantity by Application (2024-2034) & (K Tablets)
Table 73. Europe Nootropics Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Nootropics Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Nootropics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Nootropics Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Nootropics Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Nootropics Sales Quantity by Country (2018-2024) & (K Tablets)
Table 79. Europe Nootropics Sales Quantity by Country (2024-2034) & (K Tablets)
Table 80. China Nootropics Sales Quantity by Company (2018-2024) & (K Tablets)
Table 81. China Nootropics Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Nootropics Sales Quantity by Type (2018-2024) & (K Tablets)
Table 83. China Nootropics Sales Quantity by Type (2024-2034) & (K Tablets)
Table 84. China Nootropics Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Nootropics Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Nootropics Sales Quantity by Application (2018-2024) & (K Tablets)
Table 87. China Nootropics Sales Quantity by Application (2024-2034) & (K Tablets)
Table 88. China Nootropics Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Nootropics Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Nootropics Sales Quantity by Company (2018-2024) & (K Tablets)
Table 91. APAC Nootropics Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Nootropics Sales Quantity by Type (2018-2024) & (K Tablets)
Table 93. APAC Nootropics Sales Quantity by Type (2024-2034) & (K Tablets)
Table 94. APAC Nootropics Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Nootropics Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Nootropics Sales Quantity by Application (2018-2024) & (K Tablets)
Table 97. APAC Nootropics Sales Quantity by Application (2024-2034) & (K Tablets)
Table 98. APAC Nootropics Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Nootropics Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Nootropics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Nootropics Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Nootropics Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Nootropics Sales Quantity by Region (2018-2024) & (K Tablets)
Table 104. APAC Nootropics Sales Quantity by Region (2024-2034) & (K Tablets)
Table 105. Middle East, Africa and Latin America Nootropics Sales Quantity by Company (2018-2024) & (K Tablets)
Table 106. Middle East, Africa and Latin America Nootropics Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Nootropics Sales Quantity by Type (2018-2024) & (K Tablets)
Table 108. Middle East, Africa and Latin America Nootropics Sales Quantity by Type (2024-2034) & (K Tablets)
Table 109. Middle East, Africa and Latin America Nootropics Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Nootropics Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Nootropics Sales Quantity by Application (2018-2024) & (K Tablets)
Table 112. Middle East, Africa and Latin America Nootropics Sales Quantity by Application (2024-2034) & (K Tablets)
Table 113. Middle East, Africa and Latin America Nootropics Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Nootropics Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Nootropics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Nootropics Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Nootropics Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Nootropics Sales Quantity by Country (2018-2024) & (K Tablets)
Table 119. Middle East, Africa and Latin America Nootropics Sales Quantity by Country (2024-2034) & (K Tablets)
Table 120. Nootrobox Company Information
Table 121. Nootrobox Description and Overview
Table 122. Nootrobox Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 123. Nootrobox Nootropics Product and Services
Table 124. Nootrobox Nootropics SWOT Analysis
Table 125. Nootrobox Recent Developments
Table 126. Cephalon Company Information
Table 127. Cephalon Description and Overview
Table 128. Cephalon Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 129. Cephalon Nootropics Product and Services
Table 130. Cephalon Nootropics SWOT Analysis
Table 131. Cephalon Recent Developments
Table 132. Purelife Bioscience Company Information
Table 133. Purelife Bioscience Description and Overview
Table 134. Purelife Bioscience Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 135. Purelife Bioscience Nootropics Product and Services
Table 136. Purelife Bioscience Nootropics SWOT Analysis
Table 137. Purelife Bioscience Recent Developments
Table 138. Peak Nootropics Company Information
Table 139. Peak Nootropics Description and Overview
Table 140. Peak Nootropics Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 141. Peak Nootropics Nootropics Product and Services
Table 142. Peak Nootropics Nootropics SWOT Analysis
Table 143. Peak Nootropics Recent Developments
Table 144. Nootrico Company Information
Table 145. Nootrico Description and Overview
Table 146. Nootrico Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 147. Nootrico Nootropics Product and Services
Table 148. Nootrico Nootropics SWOT Analysis
Table 149. Nootrico Recent Developments
Table 150. SupNootropic Biological Technology Company Information
Table 151. SupNootropic Biological Technology Description and Overview
Table 152. SupNootropic Biological Technology Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 153. SupNootropic Biological Technology Nootropics Product and Services
Table 154. SupNootropic Biological Technology Nootropics SWOT Analysis
Table 155. SupNootropic Biological Technology Recent Developments
Table 156. AlternaScript Company Information
Table 157. AlternaScript Description and Overview
Table 158. AlternaScript Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 159. AlternaScript Nootropics Product and Services
Table 160. AlternaScript Nootropics SWOT Analysis
Table 161. AlternaScript Recent Developments
Table 162. Accelerated Intelligence Company Information
Table 163. Accelerated Intelligence Description and Overview
Table 164. Accelerated Intelligence Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 165. Accelerated Intelligence Nootropics Product and Services
Table 166. Accelerated Intelligence Nootropics SWOT Analysis
Table 167. Accelerated Intelligence Recent Developments
Table 168. Onnit Labs Company Information
Table 169. Onnit Labs Description and Overview
Table 170. Onnit Labs Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 171. Onnit Labs Nootropics Product and Services
Table 172. Onnit Labs Nootropics SWOT Analysis
Table 173. Onnit Labs Recent Developments
Table 174. Powder City Company Information
Table 175. Powder City Description and Overview
Table 176. Powder City Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 177. Powder City Nootropics Product and Services
Table 178. Powder City Nootropics SWOT Analysis
Table 179. Powder City Recent Developments
Table 180. Ceretropic Company Information
Table 181. Ceretropic Description and Overview
Table 182. Ceretropic Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 183. Ceretropic Nootropics Product and Services
Table 184. Ceretropic Recent Developments
Table 185. Nootropic Source Company Information
Table 186. Nootropic Source Description and Overview
Table 187. Nootropic Source Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 188. Nootropic Source Nootropics Product and Services
Table 189. Nootropic Source Recent Developments
Table 190. Clarity Nootropics Company Information
Table 191. Clarity Nootropics Description and Overview
Table 192. Clarity Nootropics Nootropics Sales Quantity (K Tablets), Revenue (US$ Million), Average Selling Price (ASP) (USD/Tablet) and Gross Margin (2018-2024)
Table 193. Clarity Nootropics Nootropics Product and Services
Table 194. Clarity Nootropics Recent Developments
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Nootropics Distributors List
Table 198. Nootropics Customers List
Table 199. Nootropics Market Trends
Table 200. Nootropics Market Drivers
Table 201. Nootropics Market Challenges
Table 202. Nootropics Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Nootropics Product Picture
Figure 2. Global Nootropics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nootropics Market Share by Type in 2022 & 2034
Figure 4. Attention and Focus Product Picture
Figure 5. Memory Enhancement Product Picture
Figure 6. Mood and Depression Product Picture
Figure 7. Sleep and Anxiety Product Picture
Figure 8. Others Product Picture
Figure 9. Global Nootropics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Nootropics Market Share by Application in 2022 & 2034
Figure 11. Adult
Figure 12. Kid
Figure 13. Nootropics Report Years Considered
Figure 14. Global Nootropics Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Nootropics Revenue 2018-2034 (US$ Million)
Figure 16. Global Nootropics Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Nootropics Sales Quantity 2018-2034 (K Tablets)
Figure 18. Global Nootropics Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Nootropics Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Nootropics Sales Quantity YoY (2018-2034) & (K Tablets)
Figure 21. North America Nootropics Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Nootropics Sales Quantity YoY (2018-2034) & (K Tablets)
Figure 23. Europe Nootropics Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Nootropics Sales Quantity YoY (2018-2034) & (K Tablets)
Figure 25. China Nootropics Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Nootropics Sales Quantity YoY (2018-2034) & (K Tablets)
Figure 27. APAC Nootropics Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Nootropics Sales Quantity YoY (2018-2034) & (K Tablets)
Figure 29. Middle East, Africa and Latin America Nootropics Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Nootropics Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Nootropics Revenue in 2022
Figure 32. Nootropics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Nootropics Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Nootropics Revenue Market Share by Type (2018-2034)
Figure 35. Global Nootropics Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Nootropics Revenue Market Share by Application (2018-2034)
Figure 37. North America Nootropics Revenue Market Share by Company in 2022
Figure 38. North America Nootropics Sales Quantity Market Share by Company in 2022
Figure 39. North America Nootropics Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Nootropics Revenue Market Share by Type (2018-2034)
Figure 41. North America Nootropics Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Nootropics Revenue Market Share by Application (2018-2034)
Figure 43. North America Nootropics Revenue Share by Country (2018-2034)
Figure 44. North America Nootropics Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Nootropics Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Nootropics Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Nootropics Sales Quantity Market Share by Company in 2022
Figure 48. Europe Nootropics Revenue Market Share by Company in 2022
Figure 49. Europe Nootropics Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Nootropics Revenue Market Share by Type (2018-2034)
Figure 51. Europe Nootropics Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Nootropics Revenue Market Share by Application (2018-2034)
Figure 53. Europe Nootropics Revenue Share by Country (2018-2034)
Figure 54. Europe Nootropics Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Nootropics Revenue (2018-2034) & (US$ Million)
Figure 56. France Nootropics Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Nootropics Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Nootropics Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Nootropics Revenue (2018-2034) & (US$ Million)
Figure 60. China Nootropics Sales Quantity Market Share by Company in 2022
Figure 61. China Nootropics Revenue Market Share by Company in 2022
Figure 62. China Nootropics Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Nootropics Revenue Market Share by Type (2018-2034)
Figure 64. China Nootropics Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Nootropics Revenue Market Share by Application (2018-2034)
Figure 66. APAC Nootropics Sales Quantity Market Share by Company in 2022
Figure 67. APAC Nootropics Revenue Market Share by Company in 2022
Figure 68. APAC Nootropics Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Nootropics Revenue Market Share by Type (2018-2034)
Figure 70. APAC Nootropics Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Nootropics Revenue Market Share by Application (2018-2034)
Figure 72. APAC Nootropics Revenue Share by Region (2018-2034)
Figure 73. APAC Nootropics Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Nootropics Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Nootropics Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Nootropics Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Nootropics Revenue (2018-2034) & (US$ Million)
Figure 78. India Nootropics Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Nootropics Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Nootropics Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Nootropics Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Nootropics Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Nootropics Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Nootropics Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Nootropics Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Nootropics Revenue Share by Country (2018-2034)
Figure 87. Brazil Nootropics Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Nootropics Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Nootropics Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Nootropics Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Nootropics Revenue (2018-2034) & (US$ Million)
Figure 92. Nootropics Value Chain
Figure 93. Nootropics Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed